Neil Gregory Almstead
Chief Technical Ops Officer at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $26.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 13SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,46460,299 held (−4%) | $90.25 | $222K | -28.3% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 42660,684 held (−1%) | $85.28 | $36K | -24.1% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 38560,299 held (−1%) | $86.34 | $33K | -25.1% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 8,78670,389 held (−11%) | $85.35 | $750K | -24.2% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10,09060,299 held (−14%) | $86.32 | $871K | -25.0% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,47460,299 held (−4%) | $87.03 | $215K | -25.7% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,95680,956 held (−5%) | $87.17 | $345K | -25.8% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 11,36969,587 held (−14%) | $89.03 | $1.0M | -27.3% |
| Jul 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 9,28860,299 held (−13%) | $89.44 | $831K | -27.7% |
| Jun 30SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 41260,137 held (−1%) | $85.23 | $35K | -24.1% |
| Jun 30SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 7,71860,137 held (−11%) | $85.26 | $658K | -24.1% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 40160,137 held (−1%) | $85.01 | $34K | -23.9% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,92260,137 held (−8%) | $85.03 | $419K | -23.9% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 58260,556 held (−1%) | $85.24 | $50K | -24.1% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 41960,137 held (−1%) | $86.39 | $36K | -25.1% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 8,52271,474 held (−11%) | $85.26 | $727K | -24.1% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 11,33760,137 held (−16%) | $86.51 | $981K | -25.2% |
| Jun 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10060,137 held (−0%) | $87.00 | $9K | -25.6% |
| Jun 24SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 12,13071,756 held (−14%) | $80.61 | $978K | -19.7% |
| Jun 24SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 11,61960,137 held (−16%) | $81.21 | $944K | -20.3% |
| Apr 3SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 39,39372,747 held (−35%) | $68.89 | $2.7M | -6.1% |
| Apr 3SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 12,53060,217 held (−17%) | $69.50 | $871K | -6.9% |
| Apr 3SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 8060,137 held (−0%) | $70.30 | $6K | -8.0% |
| Mar 9SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,9892,737 held (−59%) | $63.38 | $253K | +2.1% |
| Feb 20SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,056112,140 held (−3%) | $69.36 | $212K | -6.7% |
| Feb 20SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 656,726 held (−1%) | $69.36 | $5K | -6.7% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 881115,196 held (−1%) | $76.45 | $67K | -15.4% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 596,791 held (−1%) | $76.45 | $5K | -15.4% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,279117,103 held (−1%) | $76.95 | $98K | -15.9% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 546,902 held (−1%) | $76.95 | $4K | -15.9% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,026116,077 held (−1%) | $77.48 | $79K | -16.5% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 526,850 held (−1%) | $77.48 | $4K | -16.5% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 911102,189 held (−1%) | $82.63 | $75K | -21.7% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 990101,199 held (−1%) | $83.44 | $83K | -22.5% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 574100,625 held (−1%) | $84.67 | $49K | -23.6% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 689101,956 held (−1%) | $82.63 | $57K | -21.7% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 862101,094 held (−1%) | $83.35 | $72K | -22.4% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 289100,805 held (−0%) | $84.61 | $24K | -23.5% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 180100,625 held (−0%) | $85.17 | $15K | -24.0% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,790106,245 held (−3%) | $82.82 | $231K | -21.9% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,663102,582 held (−3%) | $83.41 | $306K | -22.4% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,757100,825 held (−2%) | $84.56 | $149K | -23.5% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 200100,625 held (−0%) | $85.37 | $17K | -24.2% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 13,514134,735 held (−9%) | $82.55 | $1.1M | -21.6% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 21,844112,891 held (−16%) | $83.33 | $1.8M | -22.4% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 9,171103,720 held (−8%) | $84.42 | $774K | -23.4% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,095100,625 held (−3%) | $85.15 | $264K | -24.0% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,744108,280 held (−3%) | $82.61 | $309K | -21.7% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,834103,446 held (−4%) | $83.39 | $403K | -22.4% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,621100,825 held (−3%) | $84.54 | $222K | -23.5% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 200100,625 held (−0%) | $85.34 | $17K | -24.2% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,900100,625 held (−2%) | $80.14 | $152K | -19.3% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,650100,625 held (−2%) | $80.14 | $132K | -19.3% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,715100,625 held (−4%) | $80.15 | $378K | -19.3% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 21,206100,625 held (−17%) | $80.19 | $1.7M | -19.3% |
| Nov 26SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 6,101100,625 held (−6%) | $80.17 | $489K | -19.3% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,609102,458 held (−2%) | $65.46 | $105K | -1.2% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,760100,698 held (−2%) | $66.56 | $117K | -2.8% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 73100,625 held (−0%) | $67.16 | $5K | -3.7% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 23,419128,764 held (−15%) | $65.45 | $1.5M | -1.1% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 23,863104,901 held (−19%) | $66.45 | $1.6M | -2.6% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,276100,625 held (−4%) | $67.15 | $287K | -3.6% |
- Sell
Chief Technical Ops Officer Neil Gregory Almstead sold $222K of PTCT at $90.25 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Technical Ops Officer Neil Gregory Almstead sold $36K of PTCT at $85.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Technical Ops Officer Neil Gregory Almstead sold $33K of PTCT at $86.34 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Technical Ops Officer Neil Gregory Almstead sold $750K of PTCT at $85.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Technical Ops Officer Neil Gregory Almstead sold $871K of PTCT at $86.32 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Technical Ops Officer Neil Gregory Almstead sold $215K of PTCT at $87.03 — pre-scheduled 10b5-1 plan sale.